AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32266197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pause
Number of subjects: 93
Study 32266197 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study 33357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 319349
Study 33357491 — intervention group
Group type: COMPARATOR
Intervention: No diabetes
Number of subjects: 319349
Study 33357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes (adjusted for age and sex)
Number of subjects: 319349
Study 33357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetes
Number of subjects: 319349
Study 33357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 319349
Study 33357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes risk factors
Number of subjects: 319349
Study 33357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model for COVID-19 in diabetes
Number of subjects: 319349
Study 32962031 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-active coaching intervention for three months
Number of subjects: 50
Study 32962031 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention for three months
Number of subjects: 50
Study 32962031 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-active coaching intervention
Number of subjects: 50
Study 32962031 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 50
Study 32962031 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 32962031 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 50
Study 35868015 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (CHO; 1 g CHO·kg ‐1 ·h ‐1)
Number of subjects: 18
Study 35868015 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate placebo diet (PLA; <0.1 g CHO·kg ‐1 ·h ‐1)
Number of subjects: 18
Study 35868015 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate placebo diet (PLA)
Number of subjects: 18
Study 35868015 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (CHO)
Number of subjects: 18
Study 34476479 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-based executive function intervention
Number of subjects: 29
Study 34476479 — intervention group
Group type: COMPARATOR
Intervention: Art class control activity
Number of subjects: 29
Study 33899655 — intervention group
Group type: EXPERIMENTAL
Intervention: risankizumab
Number of subjects: 2046
Study 33153764 — intervention group
Group type: EXPERIMENTAL
Intervention: PDSAFE intervention (multi-dimensional, individually tailored and progressive, home-based programme)
Number of subjects: 2587
Study 35187813 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM
Number of subjects: 20
Study 35187813 — intervention group
Group type: COMPARATOR
Intervention: Lost-wax
Number of subjects: 20
Study 33840367 — intervention group
Group type: EXPERIMENTAL
Intervention: Full windshield head-up display (FHUD)
Number of subjects: 48
Study 33840367 — intervention group
Group type: COMPARATOR
Intervention: No full windshield head-up display (Control)
Number of subjects: 48
Study 36041770 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil TCI
Number of subjects: 270
Study 36041770 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil TCI
Number of subjects: 270
Study 32799726 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and azithromycin
Number of subjects: 78
Study 32799726 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 78
Study 34069350 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective coping mechanisms instead of smoking to deal with stress
Number of subjects: 39
Study 34069350 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening effective coping skills
Number of subjects: 39
Study 34069350 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing perceived control and self-efficacy
Number of subjects: 39
Study 34360187 — intervention group
Group type: EXPERIMENTAL
Intervention: MooN program (SEM intervention)
Number of subjects: 170
Study 34360187 — intervention group
Group type: COMPARATOR
Intervention: Traditional model of direct instruction (TM-DI)
Number of subjects: 170
Study 34538089 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of brain infarcts
Number of subjects: 918
Study 34538089 — intervention group
Group type: COMPARATOR
Intervention: Prior stroke/transient ischemic attack
Number of subjects: 918
Study 34538089 — intervention group
Group type: COMPARATOR
Intervention: Modified Rankin Scale score >0
Number of subjects: 918
Study 34538089 — intervention group
Group type: COMPARATOR
Intervention: Current tobacco use
Number of subjects: 918
Study 33508848 — intervention group
Group type: COMPARATOR
Intervention: Aromatherapy
Number of subjects: 93
Study 33508848 — intervention group
Group type: COMPARATOR
Intervention: Massage therapy
Number of subjects: 93
Study 33508848 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 93
Study 34470478 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fat (1000 kcal/day for 3 weeks)
Number of subjects: 36
Study 34470478 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsaturated fat (1000 kcal/day for 3 weeks)
Number of subjects: 36
Study 34470478 — intervention group
Group type: COMPARATOR
Intervention: Simple sugars (CARB) (1000 kcal/day for 3 weeks)
Number of subjects: 36
Study 32340519 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 64
Study 32340519 — intervention group
Group type: COMPARATOR
Intervention: Open frontal sinus surgery
Number of subjects: 64
Study 36343050 — intervention group
Group type: EXPERIMENTAL
Intervention: Periorbital transcutaneous electric nerve stimulation (TENS) for 30 minutes, evoking blinking of the right eye 20 times per minute
Number of subjects: 17
Study 32851421 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP-choline (500 mg) with galantamine (16 mg)
Number of subjects: 33
Study 32851421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 33577559 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV testing and awareness of serostatus
Number of subjects: 11773
Study 33577559 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of antiretroviral treatment (ART)
Number of subjects: 11773
Study 33577559 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss to follow-up on ART
Number of subjects: 11773
Study 33577559 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO stage III/IV AIDS at first clinical visit
Number of subjects: 11773
Study 33577559 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevalence estimates
Number of subjects: 11773
Study 33577559 — intervention group
Group type: EXPERIMENTAL
Intervention: Disparity in awareness of serostatus among individuals <25 years
Number of subjects: 11773
Study 32740914 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable ADHD
Number of subjects: 1152
Study 32449336 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae block at the level of T9
Number of subjects: 66
Study 32449336 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subcostal transversus abdominis block
Number of subjects: 66
Study 32449336 — intervention group
Group type: COMPARATOR
Intervention: Opioid analgesia (control group)
Number of subjects: 66
Study 35190468 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL 0.5% bupivacaine plus 133 mg liposomal bupivacaine (LB)
Number of subjects: 70
Study 35190468 — intervention group
Group type: COMPARATOR
Intervention: 20 mL of 0.5% bupivacaine
Number of subjects: 70
Study 33548194 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac 1.5 µg
Number of subjects: 422
Study 33548194 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac 3 µg
Number of subjects: 422
Study 33548194 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac 6 µg
Number of subjects: 422
Study 33548194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study 33548194 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac 3 µg (phase 1)
Number of subjects: 422
Study 33548194 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac 6 µg (phase 1)
Number of subjects: 422
Study 33548194 — intervention group
Group type: COMPARATOR
Intervention: Placebo (phase 1)
Number of subjects: 422
Study 33548194 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 422
Study 32402509 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 32402509 — intervention group
Group type: COMPARATOR
Intervention: Definitive high-dose radiation therapy (RT)
Number of subjects: 0
Study 32402509 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study 35294969 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin-multimineral (MVM) supplement
Number of subjects: 21442
Study 35294969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21442
Study 33587993 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care planning knowledge (measured by a knowledge scale consisting of seven questions)
Number of subjects: 921
Study 33587993 — intervention group
Group type: EXPERIMENTAL
Intervention: Low knowledge
Number of subjects: 921
Study 33587993 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher knowledge
Number of subjects: 921
Study 32069463 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-guided Internet-delivered CBT-I (I-CBT-I)
Number of subjects: 134
Study 32069463 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (Control)
Number of subjects: 134
Study 35472657 — intervention group
Group type: EXPERIMENTAL
Intervention: Father interpersonal support to mothers
Number of subjects: 681
Study 35472657 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in shared household decision-making
Number of subjects: 681
Study 35472657 — intervention group
Group type: EXPERIMENTAL
Intervention: Fathers' direct engagement in stimulation activities with children
Number of subjects: 681
Study 35472657 — intervention group
Group type: EXPERIMENTAL
Intervention: Inviting fathers to the program
Number of subjects: 681
Study 32321536 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy
Number of subjects: 16
Study 32321536 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 16
Study 36297081 — intervention group
Group type: COMPARATOR
Intervention: CAF*TAU (co‐ingestion of 3 g single dose of taurine and 6 mg/kg of caffeine)
Number of subjects: 20
Study 36297081 — intervention group
Group type: COMPARATOR
Intervention: TAU (3 g single dose of taurine)
Number of subjects: 20
Study 33106278 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (OBTA)
Number of subjects: 15
Study 33106278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32119972 — intervention group
Group type: EXPERIMENTAL
Intervention: dr. Bart app
Number of subjects: 427
Study 32119972 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 427
Study 35180478 — intervention group
Group type: EXPERIMENTAL
Intervention: 10+ hours time in bed (TIB)
Number of subjects: 12
Study 35180478 — intervention group
Group type: COMPARATOR
Intervention: 8 hours time in bed (control)
Number of subjects: 12
Study 33761870 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 50
Study 33761870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 36443490 — intervention group
Group type: EXPERIMENTAL
Intervention: α-lactalbumin (40 g)
Number of subjects: 16
Study 36443490 — intervention group
Group type: COMPARATOR
Intervention: Zein (control beverage)
Number of subjects: 16
Study 36443490 — intervention group
Group type: COMPARATOR
Intervention: corn-starch (control beverage)
Number of subjects: 16
Study 33432991 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral presbyopic LASIK (Custom‐Q mode) technique
Number of subjects: 28
Study 33432991 — intervention group
Group type: COMPARATOR
Intervention: Contact lens monovision simulation
Number of subjects: 28
Study 32800962 — intervention group
Group type: EXPERIMENTAL
Intervention: Exoskeletal-assisted walking
Number of subjects: 300000
Study 32800962 — intervention group
Group type: COMPARATOR
Intervention: Standard care (wheelchair)
Number of subjects: 300000
Study 35275404 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic simulator assistance
Number of subjects: 88
Study 35275404 — intervention group
Group type: COMPARATOR
Intervention: No assistance (Control)
Number of subjects: 88
Study 33817962 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 102
Study 33788483 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at 'experienced ten acupoints' (Shangwan, Zhongwan, Xiawan, Qihai, Tianshu, Zusanli, Neiguan)
Number of subjects: 96
Study 33788483 — intervention group
Group type: COMPARATOR
Intervention: Irrelevant acupoint prescription (Feiyang, Heding, Yingu, Tianfu, Xiabai)
Number of subjects: 96
Study 35907787 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) for 24 hours
Number of subjects: 114
Study 35907787 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) for 48 hours
Number of subjects: 114
Study 35907787 — intervention group
Group type: COMPARATOR
Intervention: Both TTM durations (24h vs 48h)
Number of subjects: 114
Study 33818443 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80
Study 33818443 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 80
Study 32641338 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month ART refills
Number of subjects: 36
Study 32641338 — intervention group
Group type: COMPARATOR
Intervention: 2-month ART refills
Number of subjects: 36
Study 35438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix (1-time subcutaneous dose of 240 mg)
Number of subjects: 96
Study 35438754 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 96
Study 35438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 96
Study 35438754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 33384176 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless barbed sutures
Number of subjects: 40
Study 33384176 — intervention group
Group type: COMPARATOR
Intervention: Vicryl sutures (Control)
Number of subjects: 40
Study 36085150 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive diagnostic service (initial consultation, two-day diagnostics, follow-up consultations)
Number of subjects: 210
Study 36085150 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (comprehensive two-day diagnostic service and follow-up consultations)
Number of subjects: 210
Study 36085150 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive diagnostic service
Number of subjects: 210
Study 36085150 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 210
Study 32223601 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted Medication Therapy Management (tMTM) intervention
Number of subjects: 0
Study 32223601 — intervention group
Group type: COMPARATOR
Intervention: Control group (external samples)
Number of subjects: 0
Study 34391194 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby carrier intervention (n = 32 fathers) for three weeks
Number of subjects: 60
Study 34391194 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 28 fathers) using a baby seat
Number of subjects: 60
Study 34391194 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby carrier intervention
Number of subjects: 60
Study 32040462 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8% hyaluronic acid
Number of subjects: 30
Study 32040462 — intervention group
Group type: COMPARATOR
Intervention: Control (no hyaluronic acid)
Number of subjects: 30
Study 36168138 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS delivery of Healthy Beginnings advice
Number of subjects: 0
Study 36168138 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone delivery of Healthy Beginnings advice
Number of subjects: 0
Study 36168138 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 33734000 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) and Bright Light Therapy (BLT)
Number of subjects: 80
Study 33734000 — intervention group
Group type: COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Number of subjects: 80
Study 32299768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent or continuous selumetinib (AZD6244, ARRY-142886), tremelimumab (anti-CTLA-4), and durvalumab (anti-PD-L1)
Number of subjects: 40
Study 35401766 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 4 x 4-min bouts at 85%-95% maximal heart rate, interspersed with 3-min bouts at 50%-70% maximal heart rate, once a week for 12 months
Number of subjects: 120
Study 35401766 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group - health education
Number of subjects: 120
Study 35401766 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 120
Study 35401766 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 120
Study 32502206 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital recording system
Number of subjects: 48
Study 32502206 — intervention group
Group type: COMPARATOR
Intervention: Analogue recording system
Number of subjects: 48
Study 35703026 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 117
Study 35703026 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 32086187 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine
Number of subjects: 88
Study 32086187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 36342178 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 303
Study 36342178 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy
Number of subjects: 303
Study 33404764 — intervention group
Group type: COMPARATOR
Intervention: hard-setting calcium hydroxide (Dycal) (control group)
Number of subjects: 109
Study 33404764 — intervention group
Group type: EXPERIMENTAL
Intervention: bioactive tricalcium silicate (Biodentine)
Number of subjects: 109
Study 33404764 — intervention group
Group type: EXPERIMENTAL
Intervention: resin-based tricalcium silicate (TheraCal LC)
Number of subjects: 109
Study 34549864 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER intervention via telephone counseling for 7 weeks
Number of subjects: 94
Study 34549864 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 94
Study 32675474 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise (IHE) at 20% of maximal voluntary isometric contraction (MVIC) for 2 minutes
Number of subjects: 31
Study 32675474 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 31
Study 37721420 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 75
Study 37721420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 33392885 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive anti‐β2‐GPI antibody
Number of subjects: 64
Study 33392885 — intervention group
Group type: COMPARATOR
Intervention: Negative anti‐β2‐GPI antibody
Number of subjects: 64
Study 36197253 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EA)
Number of subjects: 60
Study 36197253 — intervention group
Group type: COMPARATOR
Intervention: Non-epidural analgesia (NEA)
Number of subjects: 60
Study 33775930 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal optimisation technique (POT)
Number of subjects: 120
Study 33775930 — intervention group
Group type: COMPARATOR
Intervention: Kissing balloon technique (KBT)
Number of subjects: 120
Study 33249424 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA alone
Number of subjects: 497
Study 33249424 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA+MMF
Number of subjects: 497
Study 35144668 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom insoles
Number of subjects: 139
Study 35144668 — intervention group
Group type: COMPARATOR
Intervention: Sham insoles
Number of subjects: 139
Study 32421521 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal tube (LT)
Number of subjects: 20
Study 32421521 — intervention group
Group type: COMPARATOR
Intervention: Bag mask ventilation (BMV)
Number of subjects: 20
Study 616442377 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain training program
Number of subjects: 77
Study 616442377 — intervention group
Group type: COMPARATOR
Intervention: Visual support training
Number of subjects: 77
Study 35879693 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) initiation
Number of subjects: 302
Study 32776518 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy with closed mouth
Number of subjects: 20
Study 32776518 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy with open mouth
Number of subjects: 20
Study 32776518 — intervention group
Group type: COMPARATOR
Intervention: Closed mouth
Number of subjects: 20
Study 32776518 — intervention group
Group type: COMPARATOR
Intervention: Open mouth
Number of subjects: 20
Study 35506888 — intervention group
Group type: EXPERIMENTAL
Intervention: Paediatric Autism Communication Therapy (PACT) - 12 sessions
Number of subjects: 160
Study 35506888 — intervention group
Group type: COMPARATOR
Intervention: Community support as usual plus psychoeducation - 5 months
Number of subjects: 160
Study 34236004 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP‐GLB lifestyle intervention
Number of subjects: 305
Study 36191485 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg tea polyphenols (TP)
Number of subjects: 65
Study 36191485 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg tea polyphenols (TP)
Number of subjects: 65
Study 36191485 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg tea polyphenols (TP)
Number of subjects: 65